AZN - Spark Newswire

1 minute read

News

AstraZeneca Announced its Alexion Unit Is Discontinuing Champion-ALS, Global Phase III Clinical Trial of Ultomiris Due to Lack of Efficacy

Today, 11:35 PM

Alexion is discontinuing CHAMPION-ALS, the global Phase III clinical trial of Ultomiris (ravulizumab) in adults with amyotrophic lateral sclerosis (ALS).

AZN

2 minute read

News

AstraZeneca Announced AZD7442 PROVENT Phase III Prophylaxis Trial Met Primary Endpoint in Preventing COVID-19

By Charles Gross

Today, 11:35 PM

Positive high-level results from the PROVENT Phase III pre-exposure prophylaxis trial showed AstraZeneca's AZD7442 achieved a statistically significant reduction in the incidence of symptomatic COVID-19, the trial's primary endpoint.

AZN

1 minute read

News

Russian Sovereign Fund RDIF Said Small-Scale Study Showed Combining AstraZeneca, Sputnik V Vaccines had Positive Result

By Charles Gross

Today, 11:35 PM

-Reuters https://www.reuters.com/article/healthcoronavirus-russia-vaccine/small-scale-study-on-mixing-sputnik-v-astrazeneca-shows-positive-result-rdif-idUSR4N2P301R

AZN

1 minute read

Oxford-Led Study Shows Efficacy Of COVID-19 Vaccines Dwindles Over Time Against Delta Variant

By Vandana Singh

Today, 11:35 PM

COVID-19 vaccines from Pfizer Inc (NYSE:PFE) – BioNTech SE (NASDAQ:BNTX) and Oxford–AstraZeneca Plc (NASDAQ:AZN) have shown effectiveness against the highly infectious Delta variant…

AZN

1 minute read

Global
News

Fauci Says Working On Expanding Capacity To Donate Hundreds Of COVID-19 Vaccine Doses To Lower, Middle Income Countries

By Michael Horton

Today, 11:35 PM

-Reuters

AZN

1 minute read

Compugen’s Out-Licensed Lung Cancer Candidate Enters Human Trial

By Vandana Singh

Today, 11:35 PM

AstraZeneca Plc’s (NASDAQ:AZN) bispecific antibody derived from Compugen Ltd’s (NASDAQ:CGEN) COM902 will advance into clinical development. AstraZeneca plans to initiate a Phase…

AZN

2 minute read

Compugen Announces Bispecific Antibody Derived From COM902 To Enter Clinical Development

By Bill Haddad

Today, 11:35 PM

Compugen Ltd. (NASDAQ:CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that a bispecific antibody of AstraZeneca derived from COM902,

AZN

3 minute read

Cannabis Movers & Shakers: Jay-Z-Backed The Parent Co. Appoints First Black CEO In Major Public Cannabis Company, CannaSafe, HEXO And Delta 9 Each Announce New Appointments

By Jelena Martinovic

Today, 11:35 PM

CannaSafe's CEO Departure, New Management Team Appointed Amid Reorganization Cannabis testing laboratory CannaSafe announced Monday that CEO Aaron Riley will leave the company to pursue testing ventures in emerging markets as part of the company's reorganization.

AZN